| BioWorld

Mice Sans Cytochrome Gene Have Ocular Drainage Irregularities That Mimic Human Congenital Glaucoma

Interleukin Cedes Majority Interest To Alticor Through Collaboration

Northfield Gets FDA Approval For Phase III Trial Of PolyHeme

PanCel Gets Telomerase License From Geron For Diabetes Program

Other News To Note

Correction

U.S. Patent Disclosures

FDA Head Says Administration Has Hatch-Waxman Under Control

WASHINGTON - FDA Commissioner Mark McClellan told a House subcommittee Thursday that legislation to close loopholes in the Hatch-Waxman Act is not necessary. (BioWorld Today) Read More

ImClone Receives $60M Payment As Part Of Revamped BMS Deal

BioWorld

March 7, 2003

Mice Sans Cytochrome Gene Have Ocular Drainage Irregularities That Mimic Human Congenital Glaucoma

Interleukin Cedes Majority Interest To Alticor Through Collaboration

Northfield Gets FDA Approval For Phase III Trial Of PolyHeme

PanCel Gets Telomerase License From Geron For Diabetes Program

Other News To Note

Correction

U.S. Patent Disclosures

FDA Head Says Administration Has Hatch-Waxman Under Control

ImClone Receives $60M Payment As Part Of Revamped BMS Deal

Today's news in brief

Today's news in brief

News in brief

In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty